Cortec principals invest significant capital in our funds alongside our limited partners. Carried interest is shared among all of the firm’s professionals. Gemspring provides flexible capital solutions to lower middle market companies headquartered primarily in the United States and Canada. We partner with industry leaders with growth potential that will benefit from our support and expertise. Cortec Group has held the final close of its eighth institutional private equity fund, Cortec Group Fund VIII LP (Fund VIII) with $3.2 billion of total capital commitments. Cortec’s newest fund closed above its target of $2.5 billion and, with approval from its limited partners, above its $3.0 billion hard cap.
Cortec Group has held the final close of its eighth institutional private equity fund, Cortec Group Fund VIII LP (Fund VIII) with $3.2 billion of total capital commitments. Cortec’s newest fund closed above its target of $2.5 billion and, with approval from its limited partners, above its $3.0 billion hard cap. After investing private capital since inception, Cortec raised its first institutional fund in 1990. In 2019, Cortec raised its seventh institutional fund, hitting its hard cap of $2.1 billion after only two months on the fund-raising trail. Prior to joining ACP, Sarah spent two years as an associate at Cortec Group, a middle market private equity firm based in New York City that focuses on specialty consumer, distribution, healthcare and specialty services and products businesses. Cortec Group Fund VII, launched in August, reached its $1.9 billion target and $2 billion hard cap after less than four months of fundraising, Managing Partner Dave Schnadig said. A commitment of about $90 million from Cortec’s general partner team brought the total to $2.1 billion, he added. The New York manager last month wrapped up Cortec Group Fund VIII at an oversubscribed $3.2 billion, co-president Dave Schnadig told Buyouts, exceeding both its $2.5 billion target and $3 billion hard-cap. The fund is easily the largest in Cortec’s 40-year history, topping by 52 percent the $2.1 billion secured by its 2019-vintage predecessor.
Prior to joining ACP, Sarah spent two years as an associate at Cortec Group, a middle market private equity firm based in New York City that focuses on specialty consumer, distribution, healthcare and specialty services and products businesses. Cortec Group Fund VII, launched in August, reached its $1.9 billion target and $2 billion hard cap after less than four months of fundraising, Managing Partner Dave Schnadig said. A commitment of about $90 million from Cortec’s general partner team brought the total to $2.1 billion, he added. The New York manager last month wrapped up Cortec Group Fund VIII at an oversubscribed $3.2 billion, co-president Dave Schnadig told Buyouts, exceeding both its $2.5 billion target and $3 billion hard-cap. The fund is easily the largest in Cortec’s 40-year history, topping by 52 percent the $2.1 billion secured by its 2019-vintage predecessor. Cortec Group Fund VIII is a private equity fund that invests in United States and Canadian companies with EBITDA of $10 to $50 million. The fund closed above its target of $2.5 billion and, with approval from its limited partners, above its $3.0 billion hard cap.